CASUS vs. APACHE II in Predicting Mortality After Coronary Artery Bypass Grafting
CASUS
The Value of CASUS vs. APACHE II in Predicting Mortality Among Patients Undergoing Coronary Artery Bypass Grafting
1 other identifier
observational
204
1 country
2
Brief Summary
The study seeks to determine the value of CASUS in predicting mortality as compared with APACHE II scoring system among patients undergoing coronary artery bypass grafting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2019
CompletedFirst Submitted
Initial submission to the registry
January 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2019
CompletedFirst Posted
Study publicly available on registry
August 30, 2021
CompletedAugust 30, 2021
August 1, 2021
2 months
January 23, 2019
August 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Mortality at 7 days
Mortality in the first 7 days after surgery
7 days
Mortality at 30 days
Mortality in the first 30 days after surgery
30 days
Secondary Outcomes (2)
Length of stay in the cardiac intensive care unit
Up to 3 months (Through study completion)
Length of the stay in the hospital
Up to 3 months (Through study completion)
Interventions
Cardiac surgery score and APACHE II will calculated on the first postoperative day.
Eligibility Criteria
Study population includes all adult patients who undergoing coronary artery bypass grafting during the study period.
You may qualify if:
- Undergoing coronary artery bypass grafting
- Over 18 years of age
- Staying at least 24 hours in the cardiac intensive care unit
You may not qualify if:
- Emergency surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital in Turkey
Istanbul, Turkey (Türkiye)
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Istanbul, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Nihan YAPICI
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery TRH
- PRINCIPAL INVESTIGATOR
Sümeyye UĞUR
Haydarpaşa Numune Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- drsumeyyeugur@gmail.com
Study Record Dates
First Submitted
January 23, 2019
First Posted
August 30, 2021
Study Start
January 2, 2019
Primary Completion
March 10, 2019
Study Completion
April 10, 2019
Last Updated
August 30, 2021
Record last verified: 2021-08